Kathryn Johnbull
Analyst · Noble Financial. Your line is now open
Thanks Zach and good morning everyone. We are pleased to report another quarter of improved financial results as we turned the corner on fiscal 2016. Turning to Slide 7, revenue for the three months ended September 30, 2016 was 27.1 million representing an increase of 10.1 million or 60% over the prior year’s fourth quarter. Higher revenue was primarily due to the inclusion of Danya as well as from additional growth across our existing contract vehicle. Revenue expanded 4.4% organically over 2015 and we believe there's plenty of room for further expansion going forward. Given our strong position at HHS, DoD, VA and the CDC along with potential new opportunities for outsourcing across the federal government. We feel optimistic about the outlook for fiscal ’17 as Zach mentioned. Now moving to gross profit on Slide 8, this quarter the company posted total gross profit of approximately 6.2 million, an increase of 2.8 or 84% versus 2015. This was driven by our higher overall revenue as well as improved contract performance. As a percent of sales, third quarter gross margin, sorry pardon me, fourth quarter gross margin was 23%, an increase of 310 basis points over the comparable period last year. As we said last quarter such margin expansion is due to the contribution from Danya along with an improved mix of more complex higher value contract combined with effective cost management on our current business - on our legacy business base. The company remains dedicated to managing expenses and continuing to post solid gross margins. Turning to Slide 9, income from operations was 1.3 million for the fiscal 2016 fourth quarter, an increase of approximately 38% over the prior-year period. Within operating income, our G&A expenses were approximately 4.1 million this quarter versus 2.4 million a year ago. This increase was primarily due to the addition of Danya combined with incremental cost tied to program management, integration advisory services and new business development. G&A as a percent of revenue was approximately 15.2% this year compared with 14.2% last year. We also have higher depreciation and amortization due to 0.7 million of intangible amortization tied to Danya acquisition. Below operating income, we had net other expenses which totaled 0.5 million this quarter versus a positive other income of 1.5 million last year, which primarily derived from the favorable closure of a legacy payroll tax issue. Generally speaking other income and expenses include non-operational acquisition expenses, interest expense, amortization of deferred debt cost and other miscellaneous non-operational items. We reported net income for the three months ended September 30. 2016 of approximately $2.4 million or $0.20 per diluted share versus $8.2 million or $0.82 per share in the prior-year period. The decrease was primarily attributable to non- operational items including principally the decrease in the amount of tax benefit reflected from our net operating loss carryforwards and last year’s favorable impact from the closure of that legacy payroll tax issue as I just mentioned. Slide 10 shows the change in adjusted EBITDA. On a non-GAAP basis adjusted EBITDA for the three month ended September 30, 2016 was approximately 2.2 million, an improvement of 1.2 million or 114% over the prior-year period. In addition, adjusted EBITDA as a percent of revenue was 8.1% compared to 6.1% in the fourth quarter of fiscal 2015 reflecting the stronger returns from our revenue as discussed previously. Our definition of adjusted EBITDA along with descriptions regarding its use and rationale is in our earnings statement. We certainly understand that the substantial non-operating items on our financials for the quarter and for the year make it challenging to compare EPS period to period. In addition to the major tax adjustments related to recognizing the value of our tax net operating losses, there was that one-time benefit from resolution of the payroll tax issue in ’15. There were also acquisition expenses in FY16 and of course there's the, the non-cash amortization of the intangible from the Danya acquisition. So to assist in comparing operating results for period to period, we've included income from operations per share in our earnings release. The main message we offer you is that FY16 represents what we believe to be the new normal for DLH, following our transformational acquisitions. And these results are indicative of what should be expected going forward. Turning to slide 11, here's a high level overview of changes in our cash position for the fiscal year. We began ’16 with roughly 5.6 million in cash and during the year generated 6 million from operations. Through debt and equity, we raised approximately 24.6 million of funds, net of repayment and during the year, of course, paid off 32.7 million primarily for the Danya acquisition, leaving us with 3.4 million as we start fiscal ’17. We remain dedicated to reducing debt going forward and de-levering the company. Our senior debt has already been brought down from -- to 23.4 million from the 30 million at closing of Danya in early May and we have approximately 5 million available under our $10 million revolving credit facility. I'm also pleased that during the quarter, we successfully raised 2.65 million to repay the subordinated debt held by Wynnefield Capital. DLH now has 11.1 million shares outstanding and the offering, the rights offering demonstrated a high level of interest in the company in its future, given the strong level of over subscription requests. Additionally, given our substantial net operating losses that we discussed previously that’s reflected through the tax benefit line, we do not anticipate being required to outlay significant cash for tax payments in the near future, which allows us to maintain our cash to support working capital needs of the company, for growth and to continue to service the outstanding debt. Before handing the call over for questions, I wanted to alert our listeners to some upcoming investor events, as shown on slide 12. We'll be presenting at the Noble Financial Growth Conference at the end of January, after which we’ll report FY17’s Q1 results on February 8. We will then host our annual shareholders meeting on February 9. We encourage our investors to participate in these activities to the extent possible. Now, let me just summarize where we stand heading in to ’17 as shown on slide 13. We believe as Zach indicated earlier that DLH is in the best shape ever in terms of its capabilities and outlook. With Danya integrated and performing as planned, we’ve strengthened our core competencies and brought some excellent employees into our organization, which we can leverage to win new business across the various agencies we serve. We believe that demand for innovative healthcare services and solutions will continue to grow across the federal sector, no matter what happens with the new administration. Given the ongoing demographic trends and requirements for health IT services and higher VA support. At the same time, we’ve paid down debt and provided improved financial flexibility to support our growth going forward and we’ll continue to be disciplined when it comes to de-levering the company. Given our existing agency contract vehicles and the solid relationships we've built over time. DLH is extremely well positioned for the opportunities of tomorrow. And we're pleased by the support shown by our employees and our investors as we enter this next phase of growth. That concludes my discussion of the financial statements. And with that, I would now like to turn the call over to our operator to open for questions.